论文部分内容阅读
我们自1997年10月～1999年10月采用胸腺肽联合乙肝1号片治疗慢性乙型肝炎30例,取得较好疗效,现报道如下: 1 一般资料 74例慢性乙型肝炎患者均为我院肝病中心门诊病人,诊断均符合1995年北京第5次全国传染病寄生虫病学术会议修订的标准,其HBeAg、HBV-DNA均为阳性,肝功能轻度异常。分为3组,治疗组30例,男24例,女6例,年龄16～56岁,其中ALT异常(ALT>46IU/L)者26例;对照1组24例,ALT异常者20例;对照2组20例,ALT异常者16例。3组患者在年龄,病程、病情方面无明显差异。
We from October 1997 to October 1999 thymosin combined with hepatitis B tablets in the treatment of chronic hepatitis B in 30 cases, and achieved good results, are reported as follows: 1 General Information 74 cases of chronic hepatitis B patients with liver disease in our hospital Center outpatients, diagnoses are in line with the 1995 Beijing Fifth National Conference on Infectious Diseases parasitic disease revised standards, the HBeAg, HBV-DNA were positive, mild liver dysfunction. Divided into three groups, the treatment group of 30 patients, 24 males and 6 females, aged 16 to 56 years, of which 26 cases of ALT abnormalities (ALT> 46IU / L); control group 1, 24 cases of ALT abnormalities in 20 cases; Control 2 group of 20 cases, 16 cases of abnormal ALT. Three groups of patients in terms of age, duration, disease no significant difference.